miR-122 An Exploratory Biomarker of Liver Injury: An Industry Perspective on the State of the Science and Experiences Pre-Clinically and Clinically The Critical Path Institute’s Predictive Safety Testing Consortium (PSTC) hosted a webinar focused on providing an industry pers
April 26, 2017-April 27, 2017 Eighth Annual Patient-Reported Outcome Consortium Workshop April 26 – 27, 2017 Hyatt Regency Bethesda, 1 Bethesda Metro Center, Bethesda, MD 20814 On April 26-27, 2017 the EIGHTH ANNUAL P
Enabling Integration of Alzheimer Disease (AD) Prevention Study Data by Application of CDISC Standards: Extension to Biometric Monitoring Device (BMD) Assessments Arnerić, S.P., et al.; “Enabling Integration of Alzheimer Disease (AD) Prevention Study Data by Application of CDISC Standards:
Two Arizona leaders in scientific collaboration partner to advance global TB research May 1, 2017 Two Arizona leaders in scientific collaboration partner to advance global TB research TUCSON and FLAGSTA
January 5, 2017 Tuberculosis and Antimicrobial Resistance – New Models of Research and Development Needed
Critical Path Institute and TGen Forge Partnership to Advance TB Research May 1, 2017 Critical Path Institute and TGen Forge Partnership to Advance TB Research TUCSON and FLAGSTAFF, May 1,
Critical Path Institute Launches Transplant Therapeutics Consortium April 26, 2017 Critical Path Institute Launches Transplant Therapeutics Consortium Tucson, Ariz., April 26, 2017 –Critical Path
April 21, 2017 Development of the Diary for Irritable Bowel Syndrome Symptoms (DIBSS) to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research
